A |
Study participation/population of interest |
1 |
Source population clearly defined |
2 |
Study population described (demographics) |
3 |
Study population represents population of interest (low-velocity extremity fractures, associated injuries, hand/feet fractures excluded) |
B |
Study attrition/followup |
4 |
Completeness of followup described |
5 |
Completeness of followup adequate (> 75% of study population for at least 6 months) |
C |
Factor of interest measurement |
6 |
Factor of interest defined in study participants to sufficiently limit potential bias (information on whether antibiotics were given) |
7 |
Factor of interest measured appropriately (adequate information on type, duration, and route of antibiotics administration) |
D |
Confounding factors measurement and account |
8 |
Confounding factors described (type of gun used, type of treatment, comorbidities) |
9 |
Confounding factors accounted for (type of gun used, type of treatment, comorbidities) |
E |
Outcome measurement |
10 |
Outcome measure defined |
11 |
Outcome measured appropriately (infection rate provided) |
F |
Results analysis |
12 |
Analysis described |
13 |
Analysis appropriate (information on superficial and deep infection provided separately) |
14 |
Analysis provides sufficient presentation of data |